Complex pharmaceuticals are difficult and expensive to stock, extremely time-sensitive, and essential to saving patients’ lives. When you need a particular complex pharmaceutical, you don’t have time to call around. You need a high-quality pharmacy services provider that can deliver within hours. You need the Nuclear Pharmacy Services business of Cardinal Health.

CPS/Rapid Response Service — call toll free 1-866-673-7747 to
our National Call Center
When your patient’s survival depends on a life-saving drug that you are out of or don’t regularly stock, one call to our National Call Center sets in motion everything you need. Available 24 x 7, it's the only local emergency source for these pharmaceuticals across the United States. Instantly, a nationwide network of pharmacies, pharmacists, and customer service associates is at your service – within a few hours providing a life-saving dose of Xigris® or delivering Antihemophilic Factors.

	Xigris® — powered by Cardinal Health Nuclear Pharmacy Services for Eli Lilly and Company, is indicated for the reduction of mortality in adult patients with severe sepsis who have a high risk of death. CPS/Rapid Response Service initiated its nationwide emergency services with Xigris. (For more information on Xigris, visit www.xigris.com.)
	Antihemophilic Factors — are indicated for patients with deficiencies in certain clotting factors, or patients who have developed inhibitors to their current antihemophilic factor medication. CPS/Rapid Response is making antihemophilic factors available on an emergency basis in selected locations.

CPS/Nuclear Therapy Service
Products. Answers. Expertise and assistance on everything from ordering a radiophamaceutical like Zevalin® to safely handling and administering it, delivery and disposal, regulatory compliance and reimbursement. That’s what you’ll receive when you contact your local Cardinal Health nuclear pharmacy to order one of two radioimmunotherapy agents used in the treatment of non-Hodgkin’s lymphoma.

	Zevalin® – Approved by the FDA in 2002, Zevalin® is indicated for certain types of non-Hodgkin’s lymphomas and is the first radioimmunotherapy agent for the treatment of cancer. It is a monoclonal antibody that is always provided in unit dose. For further clinical information about Zevalin®, go to IDEC Pharmaceuticals' www.zevalin.com website.
	Bexxar® - is a new therapeutic regimen by Glaxo Smith Kline for treating patients with follicular non-Hodgkin’s lymphoma. Find clinical information about Bexxar at www.bexxar.com

With every order . . . You get the support and solutions you need when dealing with complex pharmaceuticals. Efficient ordering and scheduling Pre-treatment consultation Radiation management assistance and services Billing and reimbursement assistance. The emphasis on safety and quality you've come to expect from Cardinal Health.